The accuracy of cell-free fetal DNA-based non-invasive prenatal testing in singleton pregnancies: a systematic review and bivariate meta-analysis

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 124, Issue 1, 2017, Pages 32-46

  Mackie, F L ^a   Hemming, K ^a   Allen, S ^b   Morris, R K ^a,b   Kilby, M D ^a,b  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b BIRMINGHAM CHILDREN S HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Cell free fetal DNA; diagnostic accuracy; non invasive prenatal testing

Indexed keywords

DNA; RHESUS D ANTIBODY; BIOLOGICAL MARKER;

ANTIBODY DETECTION; BIVARIATE ANALYSIS; CELL FREE SYSTEM; COHORT ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DNA DETERMINATION; FALSE POSITIVE RESULT; GENETIC COUNSELING; HUMAN; META ANALYSIS; MONOSOMY X; MOSAICISM; NON INVASIVE MEASUREMENT; PREGNANCY; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; REVIEW; SCREENING TEST; SENSITIVITY AND SPECIFICITY; SEX DETERMINATION; SYSTEMATIC REVIEW; TRISOMY 13; TRISOMY 18; TRISOMY 21; UNIVARIATE ANALYSIS; BLOOD; CHROMOSOME DISORDER; DOWN SYNDROME; EDWARDS SYNDROME; FEMALE; GENETICS; HIGH RISK PREGNANCY; PREDICTIVE VALUE; PROCEDURES;

BIOMARKERS; CHROMOSOME DISORDERS; DNA; DOWN SYNDROME; FEMALE; HUMANS; PREDICTIVE VALUE OF TESTS; PREGNANCY; PREGNANCY, HIGH-RISK; PRENATAL DIAGNOSIS; SENSITIVITY AND SPECIFICITY; TRISOMY 13 SYNDROME; TRISOMY 18 SYNDROME;

EID: 84973335059     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/1471-0528.14050     Document Type: Review

References (161)

1. Lo Y, Corbetta N, Chamberlain P, Rai V, Sargent IL, Redman CWG, et al. Presence of fetal DNA in maternal plasma and serum. Lancet 1997;350:485–7.
2. Bréchot P, Mouawia H, Saker A. Diagnostic prénatal non invasif de la mucoviscidose. Arch Pédiatr 2011;18:111–8.
3. Chitty LS, Barrett A, McKay F, Lench N, Daley R, Jenkins L. Non-invasive prenatal diagnosis of achondroplasia and thanatophoric dysplasia: next-generation sequencing allows for a safer, more accurate, and comprehensive approach. Prenat Diagn 2015;35:656–62.
4. Bustamante-Aragones A, Trujillo-Tiebas M, Gallego-Merlo J, Rodriguez de Alba M, Gonzalez-Gonzalez C, Cantalapiedra D, et al. Prenatal diagnosis of Huntington disease in maternal plasma: direct and indirect study. Eur J Neurol 2008;15:1338–44.
5. González-González M, Garcia-Hoyos M, Trujillo-Tiebas M, Bustamante Aragonés A, Rodriguez de Alba M, Alvarez D, et al. Improvement in strategies for the non-invasive prenatal diagnosis of Huntington disease. J Assist Reprod Genet 2008;25:477–81.
6. Lench N, Barrett A, Fielding S, McKay F, Hill M, Jenkins L, et al. The clinical implementation of non-invasive prenatal diagnosis for single-gene disorders: challenges and progress made. Prenat Diagn 2013;33:555–62.
7. Tabor A, Alfirevic Z. Update on procedure-related risks for prenatal diagnosis techniques. Prenat Diagn 2010;27:1–7.
8. Lo Y, Tein M, Lau T, Haines C, Leung T, Poon PM, et al. Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis. Am J Hum Genet 1998;62:768–75.
9. Lo Y, Zhang J, Leung T, Lau T, Chang A, Hjelm N. Rapid clearance of fetal DNA from maternal plasma. Am J Hum Genet 1999;64:218–24.
10. SMFM. Society for Maternal-Fetal Medicine (SMFM) Consult Series #36: Prenatal aneuploidy screening using cell free DNA. Am J Obstet Gynecol 2015;212:711–6.
11. Langlois S, Brock J. SOGC Committee Opinion: Current status in non-invasive prenatal detection of Down syndrome, trisomy 18, and trisomy 13 using cell-free fDNA in maternal plasma. J Obstet Gynecol Can 2013;35:177–81.
12. ISPD. Position statement from the chromosome abnormality screening committee on behalf of the board of the International Society for Prenatal Diagnosis. Charlottesville, VA: International Society for Prenatal Diagnosis; 2015 [cited 06 May 2015]. Available from: www.ispdhome.org/public/news/2015/PositionStatementFinal04082015.pdf.
13. Sonek J, Cuckle H. What will be the role of first-trimester ultrasound if cell-free DNA screening for aneuploidy becomes routine. Ultrasound Obstet Gynecol 2014;44:621–30.
14. Gil M, Quezada M, Revello R, Akolekar R, Nicolaides K. Analysis of cell-free DNA in maternal blood in screening for fetal aneuploidies: updated meta-analysis. Ultrasound Obstet Gynecol 2015;45:249–66.
15. Devaney S, Palomaki G, Scott J, Bianchi D. Noninvasive fetal sex determination using cell-free fetal DNA. JAMA 2011;306:627–36.
16. Wright C, Wei Y, Higgins J, Sagoo G. Non-invasive prenatal diagnostic test accuracy for fetal sex using cell-free DNA a review and meta-analysis. BMC Res Notes 2012;5:1–11.
17. Geifman-Holtzman O, Grotegut C, Gaughan J. Diagnostic accuracy of noninvasive fetal Rh genotyping from maternal blood – a meta-analysis. Am J Obstet Gynecol 2006;195:1163–75.
18. Zhu Y, Zheng Y, Li L, Zhou H, Liao X, Guo J, et al. Diagnostic accuracy of non-invasive fetal RhD genotyping using cell-free fetal DNA: a meta-analysis. J Maten Fetal Neonatal Med 2014;27:1839–44.
19. Rutjes A, Reitsma J, Di Nusio M, Smidt N, van Rijn J, Bossuyt P. Evidence of bias and variation in diagnostic accuracy studies. CMAJ 2006;174:469–76.
20. Cochrane. Cochrane methods working group on systematic reivews of screening and diagnostic tests: recommended methods. Cochrane, editor; 2011.
21. Deeks J. Systematic reviews in health care: systematic reviews of diagnostic and screening tests. BMJ 2001;323:157–62.
22. Khan K, Dinnes J, Kleijnen J. Systematic reviews to evaluate diagnostic tests. Eur J Obstet Gynecol Reprod Biol 2001;95:6–11.
23. Irwig L, Tosteson A, Gatsonis C, Lau J, Colditz G, Chalmers T. Guidelines for meta-analyses evaluating diagnostic tests. Ann Intern Med 1994;120:667–76.
24. Whiting P, Rutjes A, Westwood M, Mallett S, Deeks J, Reitsma J, et al. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med 2011;155:529–36.
25. Reitsma J, Glas A, Rutjes A, Scholten R, Bossuyt P, Zinderman A. Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews. J Clin Epidemiol 2005;58:982–90.
26. Takwoingi Y, Guo B, Riley R, Deeks J. Performance of methods for meta-analysis of diagnostic test accuracy with few studies or sparse data. Stats Methods Med Res 2015;24:1–19.
27. Achargui S, Tijane M, Benchemsi N. Génotypage RHD fœtal par PCR dans le plasma de femmes enceintes D négatif. Transfus Clin Biol 2011;18:13–9.
28. Aghanoori MR, Vafaei H, Kavoshi H, Mohamadi S, Goodarzi HR. Sex determination using free fetal DNA at early gestational ages: a comparison between a modified mini-STR genotyping method and real-time PCR. Am J Obstet Gynecol 2012;207:202.e1–e8.
29. Akolekar R, Farkas DH, VanAgtmael AL, Bombard AT, Nicolaides KH. Fetal sex determination using circulating cell-free fetal DNA (ccffDNA) at 11 to 13 weeks of gestation. Prenat Diagn 2010;30:918–23.
30. Alberti A, Salomon L, Le LM, Couloux A, Bussieres L, Goupil S, et al. Non-invasive prenatal testing for trisomy 21 based on analysis of cell-free fetal DNA circulating in the maternal plasma. Prenat Diagn 2015;35:471–6.
31. Al-Yatama M, Mustafa A, Ali S, Abraham S, Khan Z, Khaja N. Detection of Y chromosome-specific DNA in the plasma and urine of pregnant women using nested polymerase chain reaction. Prenat Diagn 2001;21:399–402.
32. Al-Yatama M, Mustafa A, Al-Kandari F, Khaja N, Zohra K, Monem R, et al. Polymerase-chain-reaction-based detection of fetal rhesus D and Y-chromosome-specific DNA in the whole blood of pregnant women during different trimesters of pregnancy. Med Princ Pract 2007;16:327–32.
33. Aykut A, Cotulu O, Onay H, Satol S, Ozkinay F. Determination of fetal rhd status by maternal plasma DNA analysis. Clin Genet 2010;78:S108.
34. Barrett A, McDonnell T, Chan K, Chitty L. Digital PCR analysis of maternal plasma for noninvasive detection of sickle cell anemia. Clin Chem 2012;58:1026–32.
35. Bianchi D, Parker R, Wentworth J, Mandankumar R, Saffer C, Das A. DNA sequencing versus standard prenatal aneuploidy screening. N Eng J Med 2014;370:799–808.
36. Bijok J, Gorzelnik K, Massalska D, Ilnicka A, Pawlowska B, Zimowski J, et al. Non-invasive prenatal diagnosis of the most common aneuploidies with cell-free fetal DNA in maternal serum - preliminary results. Ginekol Pol 2014;85:208–13.
37. Bombard AT, Akolekar R, Farkas DH, VanAgtmael AL, Aquino F, Oeth P, et al. Fetal RHD genotype detection from circulating cell-free fetal DNA in maternal plasma in non-sensitized RhD negative women. Prenat Diagn 2011;31:802–8.
38. Boon EMJ, Schleeht HB, Martin P, Daniels G, Vossen R, Den Dunnen JT, et al. Y chromosome detection by Real Time PCR and pyrophosphorolysis-activated DNA isolated from maternal polymerisation using free fetal plasma. Prenat Diagn 2007;27:932–7.
39. Bustamante-Aragones A, Rodriguez De Alba M, Gonzalez-Gonzalez C, Trujillo-Tiebas MJ, Diego-Alvarez D, Vallespin E, et al. Foetal sex determination in maternal blood from the seventh week of gestation and its role in diagnosing haemophilia in the foetuses of female carriers. Haemophilia 2008;14:593–8.
40. Chen H, Wang T, He G, Zhu L, Ma T. Gene analysis of free fetal DNA in maternal plasma. J Tongji Med Univ 2001;21:329–31.
41. Chen SP, Lau TK, Zhang CL, Xu CM, Xu ZF, Hu P, et al. A method for noninvasive detection of fetal large deletions/duplications by low coverage massively parallel sequencing. Prenat Diagn 2013;33:584–90.
42. Chi C, Hyett J, Finning K, Lee C, Kadir R. Non-invasive first trimester determination of fetal gender: a new approach for prenatal diagnosis of haemophilia. BJOG 2006;113:239–42.
43. Chitty L, Finning K, Wade A, Soothill P, Martin B, Oxenford K, et al. Diagnostic accuracy of routine antenatal determination of fetal RHD status across gestation: population based cohort study. BMJ 2014;349. doi:10.1136/bmj.g5243.
44. Chiu R, Lau T, Leung T, Chow K, Chui DH, Lo YM. Prenatal exclusion of beta thalassaemia major by examination of maternal plasma. Lancet 2002;360:998–1000.
45. Clausen FB, Christiansen M, Steffensen R, Jorgensen S, Nielsen C, Jakobsen MA, et al. Report of the first nationally implemented clinical routine screening for fetal RHD in D- pregnant women to ascertain the requirement for antenatal RhD prophylaxis. Transfusion 2012;52:752–8.
46. Costa JM, Benachi A, Gautier E, Jouannic JM, Ernault P, Dumez Y. First-trimester fetal sex determination in maternal serum using real-time PCR. Prenat Diagn 2001;21:1070–4.
47. Costa JM, Giovangrandi Y, Ernault P, Lohmann L, Nataf V, El Halali N, et al. Fetal RHD genotyping in maternal serum during the first trimester of pregnancy. Br J Haematol 2002;119:255–60.
48. Cremonesi L, Galbiati S, Foglieni B, Smid M, Gambini D, Ferrari A, et al. Feasibility study for a microchip-based approach for noninvasive prenatal diagnosis of genetic diseases. Ann N Y Acad Sci 2004;1022:105–12.
49. Davalieva K, Dimcev P, Efremov GD, Plaseska-Karanfilska D. Non-invasive fetal sex determination using real-time PCR. J Matern Fetal Neonatal Med 2006;19:337–42.
50. Deng ZH, Wu GG, Li Q, Zhang X, Liang YL, Li DC, et al. Noninvasive genotyping of 9 Y-chromosome specific STR loci using circulatory fetal DNA in maternal plasma by multiplex PCR. Prenat Diagn 2006;26:362–8.
51. Fan C, Blumenfeld Y, Chitkara U, Hudgins L, Quake S. Noninvasive diagnosis of fetal aneuploidy by shotgun sequencing DNA from maternal blood. PNAS 2008;105:16266–71.
52. Fernandez-Martinez FJ, Galindo A, Garcia-Burguillo A, Vargas-Gallego C, Nogues N, Moreno-Garcia M, et al. Noninvasive fetal sex determination in maternal plasma: a prospective feasibility study. Genet Med 2012;14:101–6.
53. Ferres M, Lichten L, Sachs A, Lau K, Bianchi D. Early experience with noninvasive DNA testing for aneuploidy in prenatal care. Prenat Diagn 2013;33 (Suppl 1):S72.
54. Finning K, Martin P, Summers J, Daniels G. Fetal genotyping for the K (Kell) and Rh C, C and E blood groups on cell-free fetal DNA in maternal plasma. Transfusion 2007;47:2126–33.
55. Gautier E, Benachi A, Giovangrandi Y, Ernault P, Olivi M, Gaillon T, et al. Fetal RhD genotyping by maternal serum analysis: a two-year experience. Am J Obstet Gynecol 2005;192:666–9.
56. Ge Q, Bai Y, Liu Z, Liu Q, Yan L, Lu Z. Detection of fetal DNA in maternal plasma by microarray coupled with emulsions PCR. Clin Chim Acta 2006;369:82–8.
57. Ghanta S, Mitchell M, Ames M, Hidestrand M, Simpson P, Goetsch M, et al. Non-invasive prenatal detection of trisomy 21 using tandem single nucleotide polymorphisms. PLoS ONE 2010;5:1.
58. Gorduza E, Popescu R, Caba L, Ivanov I, Martiniuc V, Nedelea F, et al. Prenatal diagnosis of 21 trisomy by quantification of methylated fetal DNA in maternal blood: study on 10 pregnancies. Rev Romana Med Lab 2013;21:275–84.
59. Grill S, Banzola I, Li Y, Rekhviashvili T, Legler TJ, Muller SP, et al. High throughput non-invasive determination of foetal Rhesus D status using automated extraction of cell-free foetal DNA in maternal plasma and mass spectrometry. Arch Gynecol Obstet 2009;279:533–7.
60. Gunel T, Kalelioglu I, Ermis H, Aydinli K. Detection of fetal RhD gene from maternal blood. J Turk Ger Gynecol Assoc 2010;11:82–5.
61. Gutensohn K, Müller S, Thomann K, Stein W, Suren A, Körtge-Jung S, et al. Diagnostic accuracy of noninvasive polymerase chain reaction testing for the determination of fetal rhesus C, C and E status in early pregnancy. BJOG 2010;117:722–9.
62. Han S, Ryu J, Bae S, Kim Y, Yang Y, Lee K. Noninvasive fetal RhD genotyping using circulating cell-free fetal DNA from maternal plasma in RhD-negative pregnant women. J Mol Diagn 2012;14:648.
63. Hill M, Finning K, Martin P, Hogg J, Meaney C, Norbury G, et al. Non-invasive prenatal determination of fetal sex: translating research into clinical practice. Clin Genet 2011;80:68–75.
64. Ho SS, Damayanti Z, Chua WY, Ng BL, Peh CM, Biswas A, et al. Non-invasive prenatal diagnosis of fetal gender using real-time polymerase chain reaction amplification of SRY in maternal plasma. Ann Acad Med Singapore 2004;33:S61–2.
65. Hofmann W, Entezami M, Haug K, Blank C, Wustemann M, Schulze B. Diagnostic accuracy for the noninvasive prenatal detection of common autosomal aneuploidies. Prenat Diagn 2013;33 (Suppl 1):75.
66. Hromadnikova I, Vechetova L, Vesela K, Benesova B, Doucha J, Vlk R. Non-invasive fetal RHD and RHCE genotyping using real-time PCR testing of maternal plasma in RhD-negative pregnancies. J Histochem Cytochem 2005;53:301–5.
67. Hromadnikova I, Vesela K, Doucha J, Nekovarova K, Duskova D, Schrollova R, et al. Non-invasive determination of fetal c and E allele of RHCE gene via real-time PCR testing of extracellular DNA extracted from maternal plasma samples using QIAamp DSP virus kit. J Turkish German Gynecol Assoc 2007;8:140–5.
68. Hwa H, Ko T, Yen M, Chiang Y. Fetal gender determination using real-time quantitative polymerase chain reaction of maternal plasma. J Formos Med Assoc 2004;103:364–8.
69. Hyett J, Gardener G, Stojilkovic-Mikic T, Finning K, Martin P, Rodeck C, et al. Reduction in diagnostic and therapeutic interventions by non-invasive determination of fetal sex in early pregnancy. Prenat Diagn 2005;25:1111–6.
70. Hyland C, Gardener G, Davies H, Ahvenainen M, Flower R, Irwin D, et al. Evaluation of non-invasive prenatal RHD genotyping of the fetus. Med J Aust 2009;191:21–5.
71. Kim SY, Lim JH, Park SY, Kim MY, Choi JS, Ryu HM. Non-invasive prenatal determination of fetal gender using QF-PCR analysis of cell-free fetal DNA in maternal plasma. Clin Chim Acta 2012;413:600–4.
72. Kolialexi A, Tounta G, Apostolou P, Vrettou C, Papantoniou N, Kanavakis W, et al. Early non-invasive detection of fetal Y chromosome sequences in maternal plasma using multiplex PCR. Eur J Obstet Gynecol Reprod Biol 2012;161:34–7.
73. Lau TK, Chen F, Pan X, Pooh RK, Jiang F, Li Y. Noninvasive prenatal diagnosis of common fetal chromosomal aneuploidies by maternal plasma DNA sequencing. J Matern Fetal Neonatal Med 2012;25:1370–4.
74. Li Y, Di Edoardo N, Vitucci A, Zimmermann B, Holzgreave W, Hahn S. Detection of paternally inherited fetal point mutations for [beta]-thalassemia using size-fractionated cell-free DNA in maternal plasma. JAMA 2005;293:843–9.
75. Li Y, Finning K, Daniels G, Hahn S, Zhong X, Holzgreve W. Noninvasive genotyping fetal Kell blood group (KEL1) using cell-free fetal DNA in maternal plasma by MALDI-TOF mass spectrometry. Prenat Diagn 2008;28:203–8.
76. Li P-Q, XZhang J, Fan J-H, Zhang Y-Z, Hou H-Y. Development of noninvasive prenatal diagnosis of trisomy 21 by RT-MLPA with a new set of SNP markers. Arch Gynecol Obstet 2014;289:67–73.
77. Liao C, Fu Y-G, Huang S-Y, Fu F, Xie G-E. Rapid noninvasive prenatal diagnosis of Down syndrome with Ion Proton. Prenat Diagn 2013;33 (Suppl 1):76.
78. Liao C, Yin A-H, Peng C-F, Fu F, Yang J-X, Li R, et al. Noninvasive prenatal diagnosis of common aneuploidies by semiconductor sequencing. PNAS 2014;111:7415–20.
79. Lim J, Park S, Kim S, Kim D, Choi J, Kim M, et al. Effective detection of fetal sex using circulating fetal DNA in first-trimester maternal plasma. FASEB J 2012;26:250–8.
80. Liu F-M, Wang X-Y, Feng X, Wang W, Ye Y-X, Chen H. Feasibility study of using fetal DNA in maternal plasma for non-invasive prenatal diagnosis. Acta Obstet Gynecol Scand 2007;86:535–41.
81. Lo Y, Hjelm N, Fidler C, Sargent I, Murphy M, Chamberlain P, et al. Prenatal diagnosis of fetal RhD status by molecular analysis of maternal plasma. N Engl J Med 1998;339:1734–8.
82. Machado I, Castilho L, Pellegrino J Jr, Barini R. Fetal rhd genotyping from maternal plasma in a population with a highly diverse ethnic background. Rev Assoc Med Bras 2006;52:232–5.
83. Manzanares S, Entrala C, Sanchez-Gila M, Fernandez-Rosado F, Cobo D, Martinez E, et al. Noninvasive fetal RhD status determination in early pregnancy. Fetal Diagn Ther 2013;35:7–12.
84. Martinhago C, de Oliveira R, Tomitão Canas M, Vagnini L, Alcantara Oliveira J, Petersen C, et al. Accuracy of fetal gender determination in maternal plasma at 5 and 6 weeks of pregnancy. Prenat Diagn 2006;26:1219–23.
85. Minon JM, Gerard C, Senterre JM, Schaaps JP, Foidart JM. Routine fetal RHD genotyping with maternal plasma: a four-year experience in Belgium. Transfusion 2008;48:373–81.
86. Mohammed N, Kakal F, Somani M, Zafar W. Non-invasive prenatal determination of fetal RhD genotyping from maternal plasma: a preliminary study in Pakistan. J Coll Physicians Surg Pak 2010;20:246–9.
87. Moise K, Boring N, O'Shaughnessy R, Simpson L, Wolfe H, Baxter J, et al. Circulating cell-free fetal DNA for the detection of RHD status and sex using reflex fetal identifiers. Prenat Diagn 2013;33:95–101.
88. Mortarino M, Garagiola I, Lotta L, Siboni S, Semprini A, Peyvandi F. Non-invasive tool for foetal sex determination in early gestational age. Haemophilia 2011;17:952–6.
89. New M, Tong Y, Yuen T, Jiang P, Pina C, Chan K, et al. Noninvasive prenatal diagnosis of congenital adrenal hyperplasia using cell-free fetal DNA in maternal plasma. J Clin Endocinol Metab 2014;99:1022–30.
90. Nicolaides KH, Syngelaki A, Gil M, Atanasova V, Markova D. Validation of targeted sequencing of single-nucleotide polymorphisms for non-invasive prenatal detection of aneuploidy of chromosomes 13, 18, 21, X, and Y. Prenat Diagn 2013;33:575–9.
91. Nicolaides K, Syngelaki A, Ashoor G, Birdir C, Touzet G. Noninvasive prenatal testing for fetal trisomies in a routinely screened first-trimester population. Am J Obstet Gynecol 2012;207:374.e1–.e6.
92. Norton M, Brar H, Weiss J, Karimi A, Laurent L, Caughey A, et al. Non-Invasive Chromosomal Evaluation (NICE) Study: results of a multicenter prospective cohort study for detection of fetal trisomy 21 and trisomy 18. Am J Obstet Gynecol 2012;207:137.e1–.e8.
93. Norton M, Jacobsson B, Swamy G, Laurent L, Ranzini A, Brar H, et al. Cell-free DNA analysis for noninvasive examination of trisomy. N Engl J Med 2015;372:1589–97.
94. Pergament E, Cuckle H, Zimmermann B, Banjevic M, Sigurjonsson S, Ryan A, et al. Single-nucleotide polymorphism-based noninvasive prenatal screening in a high-risk and low-risk cohort. Obstet Gynecol 2014;124:210–8.
95. Perlado-Marina A, Bustamente-Aragones A, Horcajada L, Trujillo-Tiebas M, Lorda-Sanchez I, Ramos M, et al. Overview of five-years of experience performing non-invasive fetal sex assessment in maternal blood. Diagnostics 2013;3:283–90.
96. Picchiassi E, Coata G, Fanetti A, Centra M, Pennacchi L, Di Renzo G. The best approach for early prediction of fetal gender by using free fetal DNA from maternal plasma. Prenat Diagn 2008;28:525–30.
97. Polin H, Reiter A, Brisner M, Danzer M, Weinberger J, Gabriel C. Clinical application of non-invasive fetal blood group genotyping in Upper Austria. Transfus Med Hemother 2013;40 (Suppl 1):36–7.
98. Porreco R, Garite T, Maurel K, Marusiak B, Ehrich M, van den Boom D. Noninvasive prenatal screening for fetal trisomies 21, 18, 13 and common sex chromosome aneuploidies from maternal blood using massively parallel genomic sequencing of DNA. Am J Obstet Gynecol 2014;211:e1–12.
99. Quezada M, Gil M, Francisco C, Orosz G, Nicolaides K. Screening for trisomies 21, 18 and 13 by cell-free DNA analysis of maternal blood at 11-13 weeks’ gestation and the combined test at 11-13 weeks. Ultrasound Obstet Gynecol 2015;45:36–41.
100. Rijnders R, Christiaens G, Bossers B, van de Smagt J, van der Schoot E, de Haas M. Clinical applications of cell-free fetal DNA from maternal plasma. Obstet Gynecol 2004;130:157–64.
101. Rijnders R, van der School CE, Bossers B, de Vroede M, Christiaens G. Fetal sex determination from maternal plasma in pregnancies at risk for congenital adrenal hyperplasia. Obstet Gynecol 2001;98:374–8.
102. Rong Y, Gao JJ, Jiang XQ, Zheng F. Multiplex PCR for 17 Y-chromosome Specific Short Tandem Repeats (STR) to enhance the reliability of fetal sex determination in maternal plasma. Int J Mol Sci 2012;13:5972–81.
103. ®. Transfus Clin Biol 2007;14:572–7.
104. Sbarsi I, Isernia P, Montanari L, Badulli C, Martinetti M, Salvaneschi L. Implementing non-invasive RHD genotyping on cell-free foetal DNA from maternal plasma: the Pavia experience. Blood Transfus 2012;10:34–8.
105. Scheffer PG, van der School CE, Page-Christiaens G, Bossers B, van Erp F, de Haas M. Reliability of fetal sex determination using maternal plasma. Obstet Gynecol 2010;115:117–26.
106. Scheffer P, Ait Soussan A, Verhagen O, Page-Christiaens G, Oepkes D, de Haas M, et al. Noninvasive fetal genotyping of human platelet antigen-1a. BJOG 2011;118:1392–5.
107. Sehnert AJ, Rhees B, Comstock D, de Feo E, Heilek G, Burke J, et al. Optimal detection of fetal chromosomal abnormalities by massively parallel DNA sequencing of cell-free fetal DNA from maternal blood. Clin Chem 2011;57:1042–9.
108. Sekizawa A, Kondo T, Iwasaki M, Watanabe A, Jimbo M, Saito H, et al. Accuracy of fetal gender determination by analysis of DNA in maternal plasma. Clin Chem 2001;47:1856–8.
109. Sesarini C, Gimenez M, Redal M, Izbizky G, Aiello H, Argibay P, et al. Non invasive prenatal genetic diagnosis of fetal RhD and sex through the analysis of free fetal DNA in maternal plasma. Arch Argent Pediatr 2009;107:405–9.
110. Shaw S, Chen C-Y, Hsiao C-H, Ren Y, Tian F, Tsai C. Non-invasive prenatal testing for whole fetal chromosome aneuploidies: a multi-center prospective cohort trial in Taiwan. Prenat Diagn 2013;33 (Suppl 1):81.
111. Sirichotiyakul S, Charoenkwan P, Sanguansermsri T. Prenatal diagnosis of homozygous alpha-thalassaemia-1 by cell-free fetal DNA in maternal plasma. Prenat Diagn 2011;32:45–9.
112. Siva S, Johnson S, McCracken S, Morris J. Evaluation of the clinical usefulness of isolation of fetal DNA from the maternal circulation. Aust N Z J Obstet Gynaecol 2003;43:10–5.
113. Song K, Ashoor G, Syngelaki A, Wagner M, Birdir C, Struble C, et al. Clinical evaluation of a directed cfDNA analysis method for non-invasive prenatal fetal trisomy detection. Prenat Diagn 2012;32:1–35.
114. Song Y, Liu C, Qi H, Zhang Y, Bian X, Liu J. Noninvasive prenatal testing of fetal aneuploidies by massively parallel sequencing in a prospective Chinese population. Prenat Diagn 2013;33:700–6.
115. Sparks A, Struble C, Wang E, Song K, Oliphant A. Noninvasive prenatal detection and selective analysis of cell-free DNA obtained from maternal blood: evaluation for trisomy 21 and trisomy 18. Am J Obstet Gynecol 2012;206:319.e1–.e9.
116. Stumm M, Entezami M, Trunk N, Beck M, Löcherbach J, Wegner R-D, et al. Noninvasive prenatal detection of chromosomal aneuploidies using different next generation sequencing strategies and algorithms. Prenat Diagn 2012;32:569–77.
117. Stumm M, Entezami M, Haug K, Blank C, Wustemann C, Schulze B, et al. Diagnostic accuracy of random massively parallel sequencing for non-invasive prenatal detection of common autosomal aneuploidies: a collaborative study in Europe. Prenat Diagn 2014;34:185–91.
118. Tong Y, Jin S, Chiu R, Ding C, Chan K, Leung T, et al. Noninvasive Prenatal Detection of Trisomy 21 by an Epigenetic-Genetic Chromosome-Dosage Approach. Clin Chem 2010;56:90–8.
119. Tsang JCH, Charoenkwan P, Chow KCK, Jin Y, Wanapirak C, Sanguansermsri T, et al. Mass spectrometry-based detection of hemoglobin E mutation by allele-specific base extension reaction. Clin Chem 2007;53:2205–9.
120. Tungwiwat W, Fucharoen G, Fucharoen S, Ratanasiri T, Sanchaisuriya K, Sae-Ung N. Application of maternal plasma DNA analysis for noninvasive prenatal diagnosis of Hb E-β-thalassemia. Transl Res 2007;150:319–25.
121. Tungwiwat W, Fucharoen S, Fucharoen G, Ratanasiri T, Sanchaisuriya K. Accuracy of fetal gender detection using a conventional nested PCR assay of maternal plasma in daily practice. Aust N Z J Obstet Gynaecol 2008;48:501–4.
122. Turner M, Martin C, O'Leary J. Detection of fetal Rhesus D gene in whole blood of women booking for routine antenatal care. Eur J Obstet Gynecol Reprod Biol 2003;108:29–32.
123. Tynan J, Angkachatchai V, Ehrich M, Paladino T, vanden BD, Oeth P. Multiplexed analysis of circulating cell-free fetal nucleic acids for noninvasive prenatal diagnostic RHD testing. Am J Obstet Gynecol 2011;204:251.e1–.e6.
124. Van den Oever JME, Balkassmi S, Johansson LF, van Scheltema PNA, Suijkerbuijk RF, Hoffer MJV, et al. Successful Noninvasive Trisomy 18 Detection Using Single Molecule Sequencing. Clin Chem 2013;59:705–9.
125. Van den Oever JME, Balkassmi S, Verweij EJ, van Iterson M, van Scheltema PNA, Oepkes D, et al. Single molecule sequencing of free DNA from maternal plasma for Noninvasive Trisomy 21 detection. Clin Chem 2012;58:699–706.
126. Vecchione G, Tomaiuolo M, Sarno M, Colaizzo D, Petraroli R, Matteo M, et al. Fetal sex identification in maternal plasma by means of short tandem repeats on chromosome X. Ann N Y Acad Sci 2008;1137:148–56.
127. Verweij E, deBoer M, van Scheltema P, van den Oever J, Boon E, Oepkes D. Non-invasive prenantal diagnosis of trisomy 21: replacing invasive testing or replacing screening? Am J Obstet Gynecol 2012;S1:S313.
128. Vora N, Johnson K, Peter I, Tighiouart H, Ralston S, Craigo S, et al. Circulating cell-free DNA levels increase variably following chorionic villus sampling. Prenat Diagn 2010;30:325–8.
129. Wagner J, Džijan S, Pavan-Jukić D, Wagner J, Lauc G. Analysis of multiple loci can increase reliability of detection of fetal Y-chromosome DNA in maternal plasma. Prenat Diagn 2008;28:412–6.
130. Wang X, Wang B, Ye S, Liao Y, Wang L, He Z. Non-invasive foetal RHD genotyping via real-time PCR of foetal DNA from Chinese RhD-negative maternal plasma. Eur J Clin Invest 2009;39:607–17.
131. Wei C, Saller D, Sutherland J. Detection and quantification by homogeneous PCR of cell-free fetal DNA in maternal plasma. Clin Chem 2001;47:336–8.
132. Zadeh NM, Mesbah-Namin A, Ala F. Noninvasive prenatal diagnosis of fetal sex by a new highly sensitive Real-time PCR. Clin Biochem 2011;44:S100–1.
133. Zhang H, Gao Y, Jiang F, Fu M, Yuan Y, Guo Y, et al. Non-invasive prenatal testing for trisomies 21, 18 and 13: clinical experience from 146 958 pregnancies. Ultrasound Obstet Gynecol 2015;45:530–8.
134. Zhong X, Holzgreve W, Hahn S. Risk free simultaneous prenatal identification of fetal Rhesus D status and sex by multiplex real-time PCR using cell free fetal DNA in maternal plasma. Swiss Med Wkly 2001;131:70–4.
135. Zhu B, Sun Q-W, Lu Y-C, Sun M-M, Wang L-J, Huang X-H. Prenatal fetal sex diagnosis by detecting amelogenin gene in maternal plasma. Prenat Diagn 2005;25:577–81.
136. Zhou L, Thorson JA, Nugent C, Davenport RD, Butch SH, Judd WJ. Noninvasive prenatal RHD genotyping by real-time polymerase chain reaction using plasma from D-negative pregnant women. Am J Obstet Gynecol 2005;193:1966–71.
137. Zimmermann B, Hill M, Gemelos G, Demko Z, Banjevic M, Baner J, et al. Noninvasive prenatal aneuploidy testing of chromosomes 13, 18, 21, X, and Y, using targeted sequencing of polymorphic loci. Prenat Diagn 2012;32:1233–41.
138. Zolotukhina TV, Shilova NV, Voskoboeva EY. Analysis of cell-free fetal DNA in plasma and serum of pregnant women. J Histochem Cytochem 2005;53:297–9.
139. Illanes S, Denbow M, Kailasam C, Finning K, Soothill PW. Early detection of cell-free fetal DNA in maternal plasma. Early Hum Dev 2007;83:563–6.
140. Santacroce R, Vecchione G, Tomaiyolo M, Sessa F, Sarno M, Colaizzo D, et al. Identification of fetal gender in maternal blood is a helpful tool in the prenatal diagnosis of haemophilia. Haemophilia 2006;12:417–22.
141. Smid M, Lagona F, de Benassuti L, Ferrari A, Ferrari M, Cremonesi L. Evaluation of different approaches for fetal DNA analysis from maternal plasma and nucleated blood cells. Clin Chem 1999;45:1570–2.
142. Song Y, Huang S, Zhou X, Jiang Y, Qi Q, Bian X, et al. Non-invasive prenatal testing for fetal aneuploidies in the first trimester of pregnancy. Ultrasound Obstet Gynecol 2015;45:55–60.
143. Zhao X, Suzumori N, Ozaki Y, Sato T, Suzumori K. Examination of fetal cells and cell-free fetal DNA in matenal blood for fetal gender determination. Gynecol Obstet Invest 2004;58:57–60.
144. Morris J, Springett A. The National Down Syndrome Cytogenetic Register for England and Wales 2012 Annual Report: Queen Mary University of London, Barts and The London School of Medicine and Dentistry, 2014.
145. Programmes NS. Fetal Anomaly Screening Programme (FASP) Standards. London: Public Health England; 2015.
146. Morris S, Karlsen S, Chung N, Hill M, Chitty L. Model-based analysis of costs and outcomes of non-invasive prenatal testing for Down's Syndrome using cell free fetal DNA in the UK National Health Service. PLoS ONE 2014;9:e935559.
147. Palomaki GE, Kloza EM, Lambert-Messerlian GM, van den Boom D, Ehrich M, Deciu C, et al. Circulating cell free DNA testing: are some test failures informative? Prenat Diagn 2015;35:289–93.
148. Mennuti M, Cherry A, Morrissette J, Dugoff L. Is it time to sound an alarm about false-positive cell free DNA testing for fetal aneuploidy? Am J Obstet Gynecol 2013;209:415–9.
149. Ma J, Pan H, Fu J, Yu L, Yang H. Perspective study of non-invasive prenatal testing using cell-free fetal DNA in high-risk population. Zhonghua Yi Xue Za Zhi 2015;95:849–52.
150. Wax J, Cartin A, Chard D, Lucas F, Pinette M. Noninvasive prenatal testing: impact of genetic counselling, invasive prenatal diagnosis, and trimsomy 21 detection. J Clin Ultrasound 2015;43:1–6.
151. Ke WL, Zhao WH, Wany XY. Detection of fetal cell-free DNA in maternal plasma for Down Syndrome, Edward Syndrome and Patau syndrome of high risk fetus. Int J Clin Exp Med. 2015;8:9525–30.
152. Ahmadi M, Amirizadeh N, Azarkeyvan A, Valikhani A, Sayyadipoor F, Navirouyan M. Fetal RHD genotyping in plasma of RH negative pregnant women by real time PCR. Vox Sang 2015;109:302.
153. Finning K, Tovey S, Desay K, Latham T, Daniels G. UK NHS blood and transplant fetal RHD screening – Giving anti-D only to those who need it!. Vox Sang 2015;109:282.
154. Gonenc G, Isci H, Yititer A, Hancer V, Buyukdotan M, Guducu N, et al. Non-invasive prenatal diagnosis of fetal RhD by using free fetal DNA. Clin Exp Obstet Gynecol 2015;42:344–6.
155. Hernandez-Gomez M, Ramirez-Arroyo E, Melendez-Hernandez R, Garduno-Zarazua L, Mayen-Molina D. Non-invasive prenatal test (NIPT) in maternal blood by parallel massive sequencing, initial experience in Mexican women and literature review. Ginecol Obstet Mex 2015;83:277–88.
156. Sago H, Sekizawa A. Nationwide demonstration project of next-generation sequencing of cell-free DNA in maternal plasma in Japan: 1-year experience. Prenat Diagn 2015;35:331–6.
157. Picchiassi E, Di Renzo G, Tarquini F, Bini V, Centra M, Pennacchi L, et al. Non-invasive prenatal RHD genotyping using cell-free fetal FNA from maternal plasma: an Italian experience. Transfus Med Hemother 2015;42:22–8.
158. Tarquini F, Picchiassi E, Centra M, Pennacchi L, Galeone F, Bini V, et al. Maternal smoking does not affect the amount of cell-free fetal DNA in maternal plasma during the 1st trimester of pregnancy. J Obstet Gynecol 2015;35:42–5.
159. Grace M, Hardisty E, Green N, Davidson E, Stuebe A, Vora N. Cell free DNA testing–interpretation of results using an online calculator. Am J Obstet Gynecol 2015;213:30.e1–.e4.
160. Bianchi D. Pregnancy: prepare for unexpected prenatal test results. Nature 2015;522:29–30.
161. Chitty L, Kroese M. Realising the promise of non-invasive prenatal testing. BMJ 2015;350:h1792.